22nd Century Group Inc (XXII)

[BiotechValues]

$XXII - For those who haven't seen this video, the cigarettes the New England Journal of Medicine used in the study were XXII ciggs, and were paid for by the FDA.

http://www.nejm.org/action/showMediaPlayer?doi=10.1056/NEJMsa1502403&aid=NEJMsa1502403_attach_1

The FDA stopped American Spirit from advertising as a lower risk or modified risk product. Now, this trial in the video bodes well for XXII as they apply to FDA to be the ONLY company in the world with the government's approval to advertise as a modified risk tobacco product or smoking cessation aid.

The MJ news today is nothing compared to what big tobacco (or big pharma?) will pay for XXII as a smoking reduction aid that has FDA approval and ultimately covered by insurance as a product with ZERO side effects of psych. drugs like Chantix.

So I think about a pharma or big tobacco partnership or buyout - it's much bigger than the MJ potential here.